Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
24.58
-0.50 (-1.99%)
At close: Jun 15, 2026, 4:00 PM EDT
24.00
-0.58 (-2.36%)
After-hours: Jun 15, 2026, 6:07 PM EDT

Genmab Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Reiterates
$65$40
BuyReiterates$65$40+62.73%Jun 2, 2026
Truist Financial
Truist Financial
Buy
Initiates
$48$40
BuyInitiates$48$40+62.73%May 27, 2026
Guggenheim
Guggenheim
Buy
Maintains
$40
BuyMaintains$40+62.73%May 26, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 19, 2026
TD Cowen
TD Cowen
Hold
Maintains
$32
HoldMaintains$32+30.19%May 8, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$34$33
HoldMaintains$34$33+34.26%May 8, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$40$38
BuyReiterates$40$38+54.60%Apr 30, 2026
Goldman Sachs
Goldman Sachs
Buy
Upgrades
$31
BuyUpgrades$31+24.08%Apr 22, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.